Global Public Health Partnering 2010-2016: Deal trends, players and financials

Publisher Name :
Date: 01-Nov-2016
No. of pages: 1000
Inquire Before Buying

"Delivery of this report will take 1-3 days after purchase."

Global Public Health Partnering 2010 to 2016 provides the full collection of Public Health disease deals signed between the world's pharmaceutical and biotechnology companies since 2010.

Trends in Public Health partnering deals

Financial deal terms for headline, upfront and royalty by stage of development

Public Health partnering agreement structure

Public Health partnering contract documents

Top Public Health deals by value

Most active Public Health dealmakers

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive Public Health disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Public Health deals.

The report presents financial deal terms values for Public Health deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.

The initial chapters of this report provide an orientation of Public Health dealmaking trends.

Chapter 1 provides an introduction to the report.

Chapter 2 provides an overview of the trends in Public Health dealmaking since 2010 covering trends by year, deal type, stage of development, technology type and therapeutic indication.

Chapter 3 includes an analysis of financial deal terms covering headline value, upfront payment, milestone payments and royalty rates.

Chapter 4 provides a review of the leading Public Health deals since 2010. Deals are listed by headline value. The chapter includes the top 25 most active Public Health dealmakers, together with a full listing of deals to which they are a party. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 5 provides comprehensive access to Public Health deals since 2010 where a deal contract is available, providing the user with direct access to contracts as filed with the SEC regulatory authorities. Each deal title links via Weblink to an online version of the deal record contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive directory of all Public Health partnering deals by specific Public Health target announced since 2010. The chapter is organized by specific Public Health therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

In addition, a comprehensive appendix is provided with each report of all Public Health partnering deals signed and announced since 2010. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in Public Health partnering and dealmaking since 2010.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Public Health technologies and products.

Report scope

Global Public Health Partnering 2010 to 2016 is intended to provide the reader with an in-depth understanding and access to Public Health trends and structure of deals entered into by leading companies worldwide.

Global Public Health Partnering 2010 to 2016 includes:

Trends in Public Health dealmaking in the biopharma industry since 2010

Analysis of Public Health deal structure

Access to headline, upfront, milestone and royalty data

Access to hundreds of Public Health deal contract documents

Comprehensive access to over 3500 Public Health deal records

The leading Public Health deals by value since 2010

Most active Public Health dealmakers since 2010

The report includes deals for the following indications: Addiction, Smoking, Drugs, Alcohol, Health education, Obesity, Preventative medicine, plus other public health indications.

In Global Public Health Partnering 2010 to 2016, available deals and contracts are listed by:

Headline value

Upfront payment value

Royalty rate value

Stage of development at signing

Deal component type

Technology type

Specific therapy indication

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The Global Public Health Partnering 2010-2016 report provides comprehensive access to available deals and contract documents for over 200 public health deals. Analyzing actual contract agreements allows assessment of the following:

What are the precise rights granted or optioned?

What is actually granted by the agreement to the partner company?

What exclusivity is granted?

What is the payment structure for the deal?

How are the sales and payments audited?

What is the deal term?

How are the key terms of the agreement defined?

How are IPRs handled and owned?

Who is responsible for commercialization?

Who is responsible for development, supply, and manufacture?

How is confidentiality and publication managed?

How are disputes to be resolved?

Under what conditions can the deal be terminated?

What happens when there is a change of ownership?

What sublicensing and subcontracting provisions have been agreed?

Which boilerplate clauses does the company insist upon?

Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?

Which jurisdiction does the company insist upon for agreement law?

Global Public Health Partnering 2010 to 2016 provides the reader with the following key benefits:

In-depth understanding of Public Health deal trends since 2010

Access Public Health deal headline, upfront, milestone and royalty data

Research hundreds of actual contracts between Public Health partner companies

Comprehensive access to over 750 links to actual Public Health deals entered into by the world's biopharma companies

Indepth review of Public Health deals entered into by the top 25 most active dealmakers

Benchmark the key deal terms companies have agreed in previous deals

Identify key terms under which companies partner Public Health opportunities

Uncover companies actively partnering Public Health opportunities

Global Public Health Partnering 2010-2016: Deal trends, players and financials

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Public Health dealmaking
2.1. Introduction
2.2. Public Health partnering over the years
2.3. Public Health partnering by deal type
2.4. Public Health partnering by industry sector
2.5. Public Health partnering by stage of development
2.6. Public Health partnering by technology type
2.7. Public Health partnering by therapeutic indication

Chapter 3 -Financial deal terms for Public Health partnering
3.1. Introduction
3.2. Disclosed financials terms for Public Health partnering
3.3. Public Health partnering headline values
3.4. Public Health deal upfront payments
3.5. Public Health deal milestone payments
3.6. Public Health royalty rates

Chapter 4 - Leading Public Health deals and dealmakers
4.1. Introduction
4.2. Most active in Public Health partnering
4.3. List of most active dealmakers in Public Health
4.4. Top Public Health deals by value

Chapter 5 - Public Health contract document directory
5.1. Introduction
5.2. Public Health partnering deals where contract document available

Chapter 6 - Public Health dealmaking by therapeutic target
6.1. Introduction
6.2. Deals by Public Health therapeutic target

Appendices
Appendix 1 - Directory of Public Health deals by company A-Z 2010 to 2016
Appendix 2 - Directory of Public Health deals by deal type 2010 to 2016
Appendix 3 - Directory of Public Health deals by stage of development 2010 to 2016
Appendix 4 - Directory of Public Health deals by technology type 2010 to 2016
Further reading on dealmaking
Deal type definitions
About Wildwood Ventures
Current Partnering
Current Agreements
Recent report titles from CurrentPartnering

List of Tables and Figures

Figure 1: Public Health partnering since 2010
Figure 2: Public Health partnering by deal type since 2010
Figure 3: Public Health partnering by industry sector since 2010
Figure 4: Public Health partnering by stage of development since 2010
Figure 5: Public Health partnering by technology type since 2010
Figure 6: Public Health partnering by indication since 2010
Figure 7: Public Health deals with a headline value
Figure 8: Public Health deals with upfront payment values
Figure 9: Public Health deals with milestone payment
Figure 10: Public Health deals with royalty rates
Figure 11: Active Public Health dealmaking activity- 2010 to 2016
Figure 12: Top Public Health deals by value since 2010
  • Global Pediatric Healthcare Market by Manufacturers, Regions, Type and Application, Forecast to 2021
    Published: 02-Dec-2016        Price: US 3480 Onwards        Pages: 117
    Pediatrics is the branch of medicine that deals with the medical care of infants and children, the age limit usually ranges from birth up to 7 years of age. Correspondingly, it is obvious that pediatric healthcare mainly involves in nutritionals, vaccines and drugs, all of which the purpose is to help children to grow up healthily. Millions of pedia die from disease, malnutrition and virus each year, as a consequence, it is quite significant to study pediatric healthcare.Scope of the ......
  • China Medical Waste Management Market Research Report 2016
    Published: 29-Nov-2016        Price: US 3200 Onwards        Pages: 105
    Notes: Sales, means the sales volume of Medical Waste Management Revenue, means the sales value of Medical Waste Management This report studies Medical Waste Management in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering - Stericycle - Sharps Compliance - Veolia Environment - Daniels Sharpsmart - Clean Harbors - MedWaste Manage......
  • Global and Chinese Artificial Blood Industry, 2016 Market Research Report
    Published: 11-Nov-2016        Price: US 2800 Onwards        Pages: 150
    The 'Global and Chinese Artificial Blood Industry, 2011-2021 Market Research Report' is a professional and in-depth study on the current state of the global Artificial Blood industry with a focus on the Chinese market. The report provides key statistics on the market status of the Artificial Blood manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Firstly, the report provides a basic overview of the industry including its def......
  • Global and Chinese Artificial blood vessel Industry, 2016 Market Research Report
    Published: 11-Nov-2016        Price: US 2800 Onwards        Pages: 150
    The 'Global and Chinese Artificial blood vessel Industry, 2011-2021 Market Research Report' is a professional and in-depth study on the current state of the global Artificial blood vessel industry with a focus on the Chinese market. The report provides key statistics on the market status of the Artificial blood vessel manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Firstly, the report provides a basic overview of the indus......
  • Global and Chinese Clinical Decision Support System Industry, 2016 Market Research Report
    Published: 11-Nov-2016        Price: US 2800 Onwards        Pages: 150
    The 'Global and Chinese Clinical Decision Support System Industry, 2011-2021 Market Research Report' is a professional and in-depth study on the current state of the global Clinical Decision Support System industry with a focus on the Chinese market. The report provides key statistics on the market status of the Clinical Decision Support System manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Firstly, the report provides a ......
  • Global and Chinese Biobank Industry, 2016 Market Research Report
    Published: 11-Nov-2016        Price: US 2800 Onwards        Pages: 150
    The 'Global and Chinese Biobank Industry, 2011-2021 Market Research Report' is a professional and in-depth study on the current state of the global Biobank industry with a focus on the Chinese market. The report provides key statistics on the market status of the Biobank manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Firstly, the report provides a basic overview of the industry including its definition, applications and m......
  • United States Medical Waste Management Market by Manufacturers, Type and Application, Forecast to 2021
    Published: 07-Nov-2016        Price: US 4480 Onwards        Pages: 105
    Medical waste management offers the full complement of medical waste disposal including solid waste, pharmaceutical waste, and document destruction. Medical waste is a subset of wastes generated at health care facilities, such as hospitals, physicians' offices, dental practices, blood banks, and veterinary hospitals/clinics, etc.Scope of the Report:This report focuses on the Medical Waste Management in United States market. This report categorizes the market based on manuf......
  • Global Dental Services Market 2016-2020
    Published: 05-Oct-2016        Price: US 2500 Onwards        Pages: 86
    Dental services market is one of the fastest emerging markets in the healthcare sector. It is one of the major revenue generators in the medical field, as it is regarded as one of the most expensive medical services being offered so far. The market is segmented based on the services offered and end-users for these dental services. The analysts forecast global dental services market to grow at a CAGR of 13.81% during the period 2016-2020. Covered in this report......
  • Global Eyewear Market with Focus on Luxury Sunglass: Industry Analysis & Outlook (2016-2020)
    Published: 01-Oct-2016        Price: US 1100 Onwards        Pages: 93
    The global eyewear market can be segmented into contact lenses and spectacles. Further, the spectacles market can be sub-segmented into: spectacle frames, spectacle lenses, and sunglasses. In spite of weakening growth, the eyewear industry remains strong, with factors such as increasing myopia and an ageing population, a growing middle class and rising disposable incomes contributing to sustained demand for eyewear. As a result, the eyewear industry is forecasted to rise in the next five year......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs